Carotid Plaque Regression With Statin Treatment Assessed by High Field Magnetic Resonance Imaging (MRI)
NCT00388843 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2015-08-24
Summary
The purpose of the study is to determine if short term (6 months) treatment with statins to lower low-density lipoprotein (LDL) in vascular disease patients with carotid plaque will be associated with a measurable reduction in carotid plaque volume using 3 Tesla MRI. The researchers will correlate the change in plaque volume to degree of LDL lowering. The researchers will also study if brief treatment will lead to change in plaque composition. The researchers will compare the change in plaque volume measured by 3T MRI with plaque burden measured by ultrasound.
Conditions
- Carotid Atherosclerosis
Sponsors & Collaborators
-
Medical College of Wisconsin
lead OTHER
Principal Investigators
-
Raymond Migrino, MD · Medical College of Wisconsin
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-08-31
- Primary Completion
- 2009-02-28
- Completion
- 2009-02-28
Countries
- United States
Study Locations
More Related Trials
-
Study of microRNAs in the Evolution of Carotid Plaque. Physiopathological and Therapeutic Interest
NCT03149406 ·Status: UNKNOWN
-
Aliskiren Effect on Aortic Plaque Progression
NCT01417104 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
TRACER [F-18] RDG-K5 Carotid Plaque Imaging Study
NCT03364270 ·Status: COMPLETED ·Phase: PHASE2
-
[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis
NCT01602471 ·Status: TERMINATED ·Phase: PHASE2
-
Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab
NCT02992301 ·Status: UNKNOWN ·Phase: PHASE4
-
Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease
NCT02388971 ·Status: WITHDRAWN ·Phase: PHASE2
-
Neuroinflammation in Asymptomatic Carotid Artery Disease - Imaging Substudy
NCT05238961 ·Status: WITHDRAWN ·Phase: PHASE1
-
Prospective Carotid Artery Stenosis Trial
NCT05724836 ·Status: RECRUITING
-
TRACER RGD-K5 Carotid Plaque Imaging Study
NCT01968226 ·Status: TERMINATED ·Phase: PHASE2
-
Investigation of Plaque Instability Using Bevacizumab-800CW and MSOT
NCT03757507 ·Status: UNKNOWN ·Phase: NA
-
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
NCT00695305 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using Gadodiamide
NCT00209443 ·Status: COMPLETED ·Phase: PHASE3
-
Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With Carotid Atherosclerotic Plaques
NCT03382249 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Arachidonic Acid Metabolism in Carotid Stenosis Plaque in Diabetic Patients
NCT03202823 ·Status: COMPLETED
-
Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation
NCT02378064 ·Status: COMPLETED ·Phase: PHASE4
-
Bacteria in Atherosclerotic Plaques and Adverse Events
NCT06935279 ·Status: COMPLETED
-
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
NCT00424866 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Physiopathological and Therapeutic Value of microRNA in the Progression of Carotid Artery Plaques: Carotid Protocol and microRNA
NCT02804659 ·Status: UNKNOWN
-
Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis
NCT01321476 ·Status: WITHDRAWN
-
A Trial of Alirocumab and Plaque Regression in Peripheral Arterial Disease
NCT02959047 ·Status: COMPLETED ·Phase: PHASE4
-
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis
NCT06902740 ·Status: RECRUITING ·Phase: PHASE4
-
Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)
NCT06204237 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Immunomodulatory Effects of PCSK9 Inhibition
NCT05720156 ·Status: WITHDRAWN
-
Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque
NCT00636766 ·Status: COMPLETED ·Phase: NA
-
Treatment of Intermittent Claudication by G-CSF-mobilized PB-MNC
NCT03683628 ·Status: UNKNOWN ·Phase: NA